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Summary
Objective: The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is applied extensively to patients with osteoarthritis
of the hip or knee. Previous work has challenged the validity of its physical function scale however an extensive evaluation of its pain scale has
not been reported. Our purpose was to estimate internal consistency, factorial validity, testeretest reliability, and the standard error of mea-
surement (SEM) of the WOMAC LK 3.1 pain scale.
Method: Four hundred and seventy-four patients with osteoarthritis of the hip or knee awaiting arthroplasty were administered the WOMAC.
Estimates of internal consistency (coefﬁcient a), factorial validity (conﬁrmatory factor analysis), and the SEM based on internal consistency
(SEMIC) were obtained. Testeretest reliability [Type 2,1 intraclass correlation coefﬁcients (ICC)] and a corresponding SEMTRT were estimated
on a subsample of 36 patients.
Results: Our estimates were: internal consistency a¼ 0.84; SEMIC¼ 1.48; Type 2,1 ICC¼ 0.77; SEMTRT¼ 1.69. Conﬁrmatory factor analysis
failed to support a single factor structure of the pain scale with uncorrelated error terms. Two comparable models provided excellent ﬁt: (1)
a model with correlated error terms between the walking and stairs items, and between night and sit items (c2¼ 0.18, P¼ 0.98); (2) a two
factor model with walking and stairs items loading on one factor, night and sit items loading on a second factor, and the standing item loading
on both factors (c2¼ 0.18, P¼ 0.98).
Conclusion: Our examination of the factorial structure of the WOMAC pain scale failed to support a single factor and internal consistency anal-
ysis yielded a coefﬁcient less than optimal for individual patient use. An alternate strategy to summing the ﬁve-item responses when consid-
ering individual patient application would be to interpret item responses separately or to sum only those items which display homogeneity.
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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SocietyIntroduction
The prevalence of total hip and knee arthroplasty has in-
creased substantially in the past decade, and with approxi-
mately 400,000 total knee replacements and 200,000 total
hip replacements being performed in the United States
each year, it is essential to have reliable and valid outcome
measures to assess the effectiveness of this intervention1.
Many self-report health status measures were originally
conceived to assess outcome in clinical trials2e6. More re-
cently, interest in applying health status measures in clinical
practice to aid decision-making concerning individual
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Received 27 July 2006; revision accepted 2 September 2006.26patients has emerged7e10. When considering patients with
osteoarthritis of the hip or knee and those subsequently pro-
gressing to total joint arthroplasty, the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC) is fre-
quently reported3,4. This paper examines selected mea-
surement properties of the WOMAC LK 3.1 pain scale
and demonstrates how measurement error expressed in
WOMAC pain scale points can be applied to assist clinical
decision-making.
At Outcome Measures in Rheumatoid Arthritis Clinical
Trials III, pain, physical function, patient’s global rating,
and imaging tests were identiﬁed as core outcomes for pa-
tients with osteoarthritis11. The WOMAC is a self-report
functional status measure which professes to assess three
health concepts, pain, stiffness, and physical functional3,12.
It has received extensive use over the past 20 years, how-
ever, recent work has consistently revealed the WOMAC
lacks factorial validity13e18. Speciﬁcally, the measure has
been shown to have greater difﬁculty distinguishing between6
267Osteoarthritis and Cartilage Vol. 15, No. 3the health concepts of pain and physical function than other
assessment methods13,14,19e21. Although one expects an
association between the concepts of pain and physical
function, this relationship appears inﬂated for the WOMAC
and it is likely related to similar item phrasing and content
on both scales22. A consequence of this spuriously high as-
sociation between pain and physical function was the WO-
MAC’s inability to detect deterioration in the functional
status of patients immediately following hip or knee arthro-
plasty when performance measures and another self-report
functional status measure detected signiﬁcant deterioration in
the ability of patients to move around19. Although the validity
of the physical function scale has been questioned, there is
support for the WOMAC’s ability to provide meaningful in-
formation concerning pain and change in pain14,15,23e28.
There are two scaling versions for WOMAC items: one
applies a 100 mm visual analog scale (VAS) (VA3 series);
the other uses a ﬁve-point Likert scale (LK3 series)12.
The WOMAC pain scale consists of ﬁve items: (1) walk-
ing on ﬂat ground; (2) going up or down stairs; (3) at
night while in bed; (4) sitting or lying; and (5) standing
upright. Total WOMAC pain scale scores can vary from
0 to 500 when VA3 scaling is applied and from 0 to 20
when LK3 scaling is implemented. In many instances
investigators have converted raw scores to a 100-point
scale9,10,29,30. The apparent rationale for this practice is
that the conversion allows a comparison with other mea-
sures converted to the scale range. However, in the ab-
sence of common means and standard deviations this
conversion does not achieve its intended goal. Moreover,
from a resource perspective, this conversion takes time
and requires a computational aid, both of which are likely
to impede its application in clinical practice. For these
reasons we believe it is of interest to present the mea-
surement properties of the WOMAC LK is the same units
as the original measurement.
Our purpose was to estimate internal consistency, facto-
rial validity, testeretest reliability, and the standard error of
measurement (SEM) of the WOMAC LK 3.1 pain scale. A
second goal was to illustrate how error estimates for the
pain scale can be used to indicate the conﬁdence in re-
ported WOMAC LK 3.1 individual patient pain scores and
change scores.
Methods
PATIENTS
Our sample consisted of 474 patients with osteoarthritis
of the hip or knee. All patients were awaiting primary total
hip or knee arthroplasty. Two hundred and forty (51%) pa-
tients were female. Two hundred and fourteen patients
(45%) had hip osteoarthritis of whom 95 were female. The
sample’s mean age (S.D.) and body mass index were
63.5 years (10.3) and 30.8 kg/m2 (5.7), respectively. All
patients contributed data to the estimation of internal con-
sistency, factorial validity, and the SEM based on internal
consistency (SEMIC). Testeretest reliability and a SEM
based on testeretest reliability (SEMTRT) were calculated
from a convenience subsample of 36 patients who were as-
sessed on two occasions. Nineteen (52%) of these patients
were female. Twenty patients (56%) had hip osteoarthritis
of whom 10 were female. The testeretest reliability subsam-
ple’s mean age and body mass index were 63 years (10.5)
and 29.4 kg/m2 (5.5), respectively. All patients provided in-
formed consent and the project was approved by the insti-
tution’s research and ethics committee.DESIGN
A cross-sectional study design was applied to obtain es-
timates of internal consistency, factorial validity, and SEMIC.
Data for the testeretest reliability sample were collected at
two regularly scheduled clinic visits prior to surgery. The in-
terval between assessments varied somewhat with the me-
dian interval being 106 days (ﬁrst, third quartiles: 78, 133).
Previous work has reported that similar patients were rea-
sonably stable over a similar interval31.
MEASURE
We administered the entire WOMAC LK 3.1, however, in-
formation from the pain scale only is of interest to this study.
The pain scale consists of ﬁve items and all items are scored
on a ﬁve-point scale (0e4) with higher scores representing
greater levels of pain32. Accordingly, pain scores can vary
from 0 to 20. The ﬁve pain items are as follows: (1) walking
on ﬂat ground; (2) going up or down stairs; (3) at night while
in bed; (4) sitting or lying; and (5) standing upright.
ANALYSIS
We calculated descriptive statistics and examined the
distributions of scores for the entire sample and difference
scores (Time 2 minus Time 1) for the testeretest reliability
subsample. We calculated Pearson’s correlation coefﬁ-
cients between WOMAC pain items. We calculated coefﬁ-
cient a as an index of internal consistency, and the SEMIC
as ‘ s
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 ap ’ where ‘s’ is equal to the standard deviation
(S.D.) and ‘a’ is coefﬁcient alpha.
Conﬁrmatory factor analysis applying a maximum likeli-
hood estimation method (AMOS 4.0, SmallWaters Corpora-
tion) was applied to assess the factorial structure of the pain
scale33. We conceptualized a one factor measurement
model with uncorrelated error terms34. The following in-
dexes were applied to assess model ﬁt: Comparative Fit In-
dex (CFI); Relative Fit (RF); Tucker-Lewis Index (TLI); Root
Mean-Square Error of Approximation (RMSEA); and the
model ﬁt chi-square and associated P-value34. Although
no single standard exists deﬁning an acceptable ﬁtting
model, the following values are generally accepted; CFI,
RF, and TLI values exceeding 0.95 indicate good ﬁt;
RMSEA values less than 0.05 represent good ﬁt and values
less than 0.08 indicate reasonable ﬁt34,35.
We performed a randomized block analysis of variance
and calculated patient, time, and residual error variance com-
ponents. These variance components were used to calculate
Shrout and Fleiss Type 2,1 intraclass correlation coefﬁcients
(ICC2,1¼ patient variance/total variance)36. We also calcu-
lated the SEM ðSEMTRT ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
residual variance
p Þ37. Error esti-
mates for score values were obtained by multiplying SEMs
based on internal consistency and testeretest by 1.65, the
Z-value associatedwith a two-sided 90%conﬁdence interval.
Minimal detectable change at a 90% conﬁdence level
was calculated as follows: SEMTRT  1:65
ﬃﬃﬃ
2
p
38,39. The
ﬃﬃﬃ
2
p
term acknowledges two measurements are being compared
and the value 1.65 is the Z-value associated with a two-sided
90% conﬁdence interval. The interpretation of minimal de-
tectable change (MDC90) is that 90% of stable patients will
display random ﬂuctuations equal to or less than this value
when assessed on multiple occasions.
Results
Table I provides a summary of the WOMAC pain items’
descriptive statistics. Item means and standard deviations
268 P. W. Stratford et al.: WOMAC pain scale measurement propertiesare reported on the main diagonal and inter-item correla-
tions are presented in the other cells. Figure 1(a and b) dis-
play the distribution of WOMAC pain scores for the entire
patient sample and reliability subsample, respectively.
Table II displays summary statistics for the entire sample
and testeretest reliability subsample. Also reported in Table
II are estimates of SEMIC, SEMTRT, coefﬁcient a, the Type
2,1 ICC, and MDC90. The variance components used to cal-
culate the Type 2,1 ICC were as follows: (1) patients 9.35;
Table I
WOMAC pain items’ descriptive statistics
Walk Stair Night Sit Stand
Walk 2.1 (0.9)*
Stair 0.70y 2.5 (0.9)
Night 0.43 0.39 1.8 (1.0)
Sit 0.51 0.46 0.62 1.6 (0.9)
Stand 0.59 0.55 0.45 0.54 1.9 (0.9)
*Mean and S.D.
yPearson’s correlation coefﬁcient.
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Fig. 1. (a) Distribution of WOMAC pain scores for entire sample
(n ¼ 474). (b) Distribution of WOMAC pain difference scores for
testeretest reliability sample (n¼ 36).(2) time 0; and (3) error 2.86. The zero variance associated
with time term supports the premise that no systematic dif-
ference in pain intensity occurred between test and retest.
The testeretest ICC was slightly less than the estimated
values for coefﬁcient a and SEMTRT was marginally greater
than the estimates for SEMIC.
Table III summarizes the ﬁt statistics for the conﬁrmatory
factor analysis and Fig. 2 illustrates the one factor model in-
cluding the factor loadings. Our hypothesized model of a sin-
gle factor with uncorrelated error terms demonstrated
a highly signiﬁcant lack of ﬁt. Speciﬁcally, modiﬁcation in-
dexes alerted us to signiﬁcant correlations between ‘‘at
night while in bed’’ and ‘‘sitting or lying’’ error terms and
‘‘walking on ﬂat ground’’ and ‘‘going up or down stairs’’ error
terms (modiﬁcation indexes: nightesit 71.6, walkestair
29.8). To provide an insight into the factorial structure of
the pain scale, we constructed two modiﬁed models. The
correlated error model speciﬁed correlations between the
night and sit error terms, and the walk and stair error terms
[Fig. 3(a)]; the two factor model conceptualized walk and
stair items loading on one factor, night and sit items loading
on a second factor, and standing loading on both factors
[Fig. 3(b)]. The ﬁt statistics for both modiﬁed models were
identical.
Discussion
The rationale for summing multiple item responses into
a single score is that the items are measuring a common
trait or health concept. Factor analysis is a statistical tech-
nique which determines the extent to which responses
Table II
Summary statistics for WOMAC pain scores
Entire sample
(n¼ 474)
Testeretest
sample (n¼ 36)
Time 1 score (mean, s*) 9.98 (3.66) 7.75 (3.66)
Internal consistency measurements
Coefﬁcient a (95% CIz) 0.84 (0.82, 0.87) NAy
SEM (95% CI) 1.48 (1.33, 1.57) NA
Testeretest measurements
Time 2 score (mean, s) NA 7.97 (3.32)
Difference score (mean, s) NA 0.22 (2.39)
Intraclass correlation
coefﬁcient (95% CI)
NA 0.77 (0.59, 0.88)
SEM (95% CI) NA 1.69 (1.37, 2.21)
Minimal detectable
change (90%)
NA 3.94
*S.D., not applicable.
yNot applicable.
zConﬁdence interval.
Table III
Confirmatory factor analysis fit statistics
Initial model Correlated
error model
Two factor
model
c2 (df*, P) 105.76
(5, <0.01)
0.18
(3, 0.98)
0.18
(3, 0.98)
CFI 0.90 >0.99 >0.99
RF 0.79 >0.99 >0.99
TLI 0.80 >0.99 >0.99
RMSEAy 0.21 <0.01 <0.01
*Degrees of freedom.
yRoot mean-square error of approximation.
269Osteoarthritis and Cartilage Vol. 15, No. 3from multiple items can be represented by a smaller number
of health concepts (factors); internal consistency examines
the homogeneity of responses from a set of items. The
WOMAC pain scale consists of ﬁve items conceived to
assess a single health concept and a total score is obtained
by summing the item responses. This approach would be
reasonable provided the results from a factor analysis pro-
duced a single factor and the set of items displayed
a high degree of internal consistency.
We applied a conﬁrmatory factor analysis and found that
our hypothesized model of a single factor with uncorrelated
error terms did not ﬁt the data for the ﬁve WOMAC pain
scale items. However, excellent ﬁt was obtained from two
modiﬁed models. One model speciﬁed correlations between
the night and sit items’ error terms, and the walk and stair
items’ error terms; the second model speciﬁed two factors
with walk and stair items loading on one factor, night and
sit items loading on a second factor, and the standing
item loading on both factors. It is not a coincidence that
both modiﬁed models produced the same ﬁt statistics as
the models essentially convey equivalent information con-
cerning the relationship among pain items. We presented
the two factor model to make explicit the impact of corre-
lated error terms: something more than pain is inﬂuencing
patients’ responses to WOMAC pain items. We cannot
say with certainty what this isdpossible explanations in-
clude similarity of item content and yea-saying as the items
with correlated error terms are adjacent to each other on the
questionnairedhowever, it is important to note that factor
analysis examines the covariance of responses among
items and not the magnitude of responses. Accordingly,
the fact that the night and sit items have lower pain scores
should not be interpreted as causally inﬂuencing the asso-
ciation among items.
Several studies have investigated the factorial structure
of the WOMAC pain scale using exploratory factor analysis
(principal component analysis). Faucher et al. commenting
on 88 patients with osteoarthritis of the knee, reported the
pain 
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Fig. 2. Initial conﬁrmatory factor analysis model with factor loadings.following factor loadings which accounted for 50% of the
variance: (walk) 0.77; (stair) 0.61; (night) 0.63; (sit) 0.78;
(stand) 0.7214. Guermazi et al. reporting on fewer than 50
patients (actual number not speciﬁed) with osteoarthritis of
the knee, provided the following factor loadings which
accounted for 53% of the variance: (walk) 0.73; (stair)
0.78; (night) 0.65; (sit) 0.71; (stand) 0.7417. Finally, Bellamy
et al. also performed a principal component analysis on 17
patients with osteoarthritis of the knee, however, with this
extremely small sample size the results cannot be inter-
preted with conﬁdence40. Although these factor loadings
are comparable to those reported in our single factor model
shown in Fig. 2, they were estimated using principal compo-
nent analysis and cannot be compared directly.
Guidelines for interpreting the magnitude of reliability co-
efﬁcients for high stakes decisions concerning individuals
pain
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Fig. 3. (a) Modiﬁed conﬁrmatory factor analysis model with corre-
lated error terms and factor loadings. (b) Modiﬁed conﬁrmatory fac-
tor analysis model with two factors and factor loadings.
270 P. W. Stratford et al.: WOMAC pain scale measurement propertiessuggest a minimum value of 0.90 and ideally 0.9541,42. Our
estimate of internal consistency was 0.84 and this is similar
to published values which typically fall between 0.79 and
0.914,27,28,43e45. Likewise, our estimate of testeretest reli-
ability is reasonably consistent with reported values which
are in the range of 0.77e0.86 for reassessment intervals
of less than 22 days27,28.
The consequence of questionable factorial structure and
less than optimal internal consistency is to increase the er-
ror and decrease the conﬁdence associated with a reported
patient’s score. The SEM represents error in the same units
as the original measurement and we have reported two
SEMs. One SEM was based on internal consistency and
the other on testeretest reliability. SEMIC is appropriate if
one is interested in estimating the measurement error at
an instant in time. As such it assumes that time stands still
and the estimated score cannot be generalized beyond the
instant in time at which a patient was assessed. Because
a clinician is usually interested in generalizing a patient’s
scoredsay several days before the assessment or a day
or two laterdbeyond the instant at which the assessment
occurred, an error estimate based on SEMIC alone has little
practical application. By contrast, random ﬂuctuations in
a stable patient’s reported score over time are included in
SEMTRT. Accordingly, SEMTRT is more appropriate when
the intent is to generalize beyond the instant in time at
which the test was performed. Although not intuitively obvi-
ous, SEMIC and SEMTRT share a common source of error
variance which is inﬂuenced by the internal consistency.
Accordingly, improving the internal consistency of a mea-
sure decreases both SEMIC and SEMTRT and increases
one’s conﬁdence in a patient’s reported score.
Our estimates for SEMIC and SEMTRT were 1.48 and 1.69
WOMAC pain points, respectively. These values are con-
sistent with estimates obtained from other investiga-
tions31,45. For example, although Salafﬁ et al. did not
report SEMs, it is possible to calculate from their report
the values of 1.33 and 1.65 for SEMIC and SEMTRT, respec-
tively, for the 20-point pain scale28. Similarly, estimates of
1.42 and 1.97 for SEMIC and SEMTRT were calculated
from Roorda et al.’s study. Quintana et al. administered
the Likert version of the WOMAC and converted their
scores values out of 10045. These authors reported esti-
mates of SEMIC of 7.71 and 8.24 (out 100 points) for pa-
tients receiving total hip and knee joint replacement,
respectively45. Converting their reported SEMIC values to
the 20-point Likert scale, SEMIC values of 1.54 and 1.65
WOMAC pain points were obtained for the hip and knee
samples, respectively. Kelly et al. in a study which exam-
ined the impact of waiting time on patients scheduled for to-
tal hip or knee arthroplasty administered the VAS version of
the WOMAC31. These authors concluded that the waiting
time did not impact on the pain or physical function of pa-
tients as the mean changes in pain and function were 1
and 1.6 points, respectively, on a 100-point scale. Kelly
et al. also presented the S.D. of the change scores and
from these values we estimated SEMTRT. Converting Kel-
ly’s values, we obtained SEMTRT estimates of 1.88 and
2.16 for the hip and knee samples, respectively. In sum-
mary, SEMs obtained from the reports of other investigators
fall within the 95% conﬁdence interval for our estimated
values.
The second purpose of this paper was to illustrate how in-
formation from measurement studies reporting SEMTRT can
be used to assist clinical decision-making concerning the
conﬁdence in a patient’s score or change score. For the
purpose of this illustration we will accept the estimatedvalue for SEMTRT obtained from our study. One SEM is as-
sociated with a 68% conﬁdence interval, however, in prac-
tice clinicians often desire greater certainty in their
decisions and multiples of the SEMd1.65 for 90% and
1.96 for 95%dare frequently applied. To illustrate the appli-
cation of the SEM, consider a patient who at the initial as-
sessment reports a WOMAC pain score of 10/20, and at
a subsequent assessment a score of 6/20. Applying an
SEMTRT of 1.69 the following can be said: (1) the 90% con-
ﬁdence interval for this patient’s initial pain score is from 7.2
to 12.8; (2) the 90% conﬁdence interval for the follow-up
score is from 3.2 to 8.8; and (3) 90% of truly unchanged pa-
tients will display random ﬂuctuations of 3.9 WOMAC pain
points when assessed on two occasions and we interpret
the observed change of four points to represent a true
change for this patient.
There are several limitations associated with our work.
First, our sample size for the testeretest component of
this investigation was based on convenience and not a for-
mal sample size calculation. The impact of this is a larger
conﬁdence interval width. For example, if one desired
a lower one-sided 97.5% conﬁdence interval width of
0.10, a sample size of 90 patients would be necessary as-
suming an obtained testeretest reliability of 0.7746. A sec-
ond limitation is the extent to which our ﬁndings based on
patients awaiting hip or knee arthroplasty are generalizable
to all patients with osteoarthritis of the hip or knee on whom
the WOMAC would be applied. A potential limitation for
those interested in assessing patients with a smaller interval
between assessments than that reported in our study is that
the magnitude of measurement error may be related to the
interval between assessments. Conceivably, a shorter inter-
val between assessments may be associated with a smaller
amount of measurement error however our estimated value
was consistent with those calculated from the works of
others who studied patients over a variety of retest intervals.
In summary, our examination of the factorial structure of
the WOMAC pain scale failed to support a single factor
and internal consistency analysis yielded a coefﬁcient less
than optimal for individual patient use. Collectively, these
ﬁndings question the wisdom of summing the ﬁve WOMAC
pain scale item responses into a single score. An alternate
strategy when considering individual patient application
would be to interpret item responses separatelydpreferably
with a minimum of seven response options per itemdor to
sum only those items which display homogeneity.
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